Serotonin infusions inhibit sensory input from the dural vasculature

Cephalalgia

Volumn 19, Issue 7, 1999, Pages 639-650

  Lambert, G A ^a   Shimomura, T ^b   Boers, P M ^b   Gordon, V ^b   Donaldson, C ^b   Zagami, A S ^b  

^a PRINCE HENRY HOSPITAL   (Australia)

^b NONE

Author keywords

5HT; Dura mater; Migraine; Trigeminal

Indexed keywords

METHYSERGIDE; METITEPINE; SEROTONIN ANTAGONIST; SEROTONIN CREATININE SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; DURA MATER; ELECTROSTIMULATION; MIGRAINE; NERVE CELL STIMULATION; NONHUMAN; SPINAL CORD NERVE CELL; SUPERIOR SAGITTAL SINUS;

ACTION POTENTIALS; ANIMALS; CATS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRANIAL SINUSES; DURA MATER; ELECTRIC STIMULATION; HEMODYNAMIC PROCESSES; HYDROXYINDOLEACETIC ACID; INFUSIONS, INTRAVENOUS; METHIOTHEPIN; METHYSERGIDE; MIGRAINE DISORDERS; NEURONS, AFFERENT; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SPINAL CORD; SYSTOLE; TRIGEMINAL NUCLEI;

EID: 0032829617     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1999.019007639.x     Document Type: Article

References (55)

1. Kimball RW, Friedman AP, Vallejo E. Effect of serotonin in migraine patients. Neurology 1960;10:107-11
2. Anthony M, Hinterberger H, Lance JW. Plasma serotonin in migraine and stress. Arch Neurol 1967;16:544-52
3. Hopf HC, Johnson EA, Gutmann L. Protective effect of serotonin on migraine attacks. Neurology 1992;42:1419
4. Spira PJ, Mylecharane EJ, Lance JW. The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey. Res Clin Stud Headache 1976;4:37-75
5. Lambert G, Michalicek J. Effect of antimigraine drugs on dural blood flows and resistances and the response, to trigeminal stimulation. Eur J Pharmacol 1996;311:141-51
6. Humphrey PPA, Connor HE, Stubbs CM, Feniuk W. Effect of sumatriptan on pial vessel diameter in vivo. In: Olesen J, editor. Migraine and other headaches. The vascular mechanisms. New York: Raven Press, 1991:335-8
7. Moskowitz MA. Neurogentc inflammation in the pathophysiology and treatment of migraine. Neurology 1993;43 Suppl 3:S16-20
8. Lambert GA, Lowy AJ, Boers PM, Angus-Leppan H, Zagami AS. The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids. Brain Res 1992;597:321-30
9. Cumberbatch MJ, Hill RG, Hargreaves RJ. Rizatriptan has central antinociceptive effects against durally evoked responds. Eur J Pharmacol 1997;328:37-40
10. Cumberbatch MJ, Hill RG, Hargreaves RJ. Differential effects of naratriptan on spinal vs trigeminal nociceptive responses. Cephalalgia 1997;17:381
11. 1B/1D ) receptors. Br J Pharmacol 1997;122:918-22
12. Kaube H, Hoskin KL, Coadsby PJ. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol 1993;109:788-92
13. Cumberbatch MJ, Hill RG, Hargreaves RJ. The effects of 5HT1A, 5HT1B and 5HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. Eur J Pharmacol 1998;362:43-6
14. Lambert GA, Shimomura T, Boers P, Gordon V, Zagami AS. Intravenous infusions of serotonin suppress responsiveness of second order trigeminovascular sensory neurons. Cephalalgia 1997;17:380
15. 1B/1D receptor-a central action in migraine. Ann Neurol 1998;43:711-8
16. Hu JW, Dostrovsky JO, Sessle BJ. Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary), dorsal hom). I. Responses to oral-facial noxious and non-noxious stimuli and projections to thalamus and subnucleus caudalis. J Neurophysiol 1981;45:173-91
17. Nagler J, Conforti N, Feldman S. Alterations produced by cortisol in the spontaneous activity and responsiveness to sensory stimulation of single cells in the tuberal hypothalamus of the rat. Neuroendocrinology 1973;12:52-6
18. Da Prada M, Picotti GB. Content and subcellular localisation of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma. Br J Pharmacol 1979;65:653-62
19. Feldberg W, Sherwood SL. A permanent cannula for intraventricular injections in cats. J Physiol 1953;120:3P
20. Merlis JK. The effect of changes in the calcium content of the cerebrospinala fluid on spinal reflex activity in the dog. Am J Physiol 1940;131:67-72
21. Helke CJ, Dias Souza J, Gillis RA. Interaction of serotonin and deslanoside on cardiac rhythm in the cat. Eur J Pharmacol 1978;51:167-77
22. Humphrey JH, Jaques R. The histamine and serotonin content of the platelets and polymorphonuclear leucocytes of various species. J Physiol 1954;124:305-10
23. Smith G, Smith AN. The role of serotonin in experimental pulmonary embolism. Surg Gynecol Obstet 1955;101:691-9
24. Sanders R, Waalkes TP, Gilbert JW, Terry LL. Serotonin (5-hydroxytryptamine) and pulmonary thromboembolism. Surg Gynecol Obstet 1959;30:455-9
25. Ross SB, Aperia B, Beck-Friis J, Jansa S, Wetterberg L, Aberg A. Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in viva. Psychopharmacology 1980;67:1-7
26. Cheng, F-C, Yang, L-L, Chang, F-M, Chia, L-G, Kuo, J-S. Simultaneous measurement of serotonin, catecholamines and their metabolites in cat and human plasma by in vitro microdialysis-microbore high-performance liquid chromatography with amperometric detection. J Chromatogr 1992;582:19-27
27. Pettersson G, Ahlman H, Bhargava HN, Dahlstrom A, Kewenter J, Larsson I. The effect of propranolol on the serotonin concentration in the portal plasma after vagal nerve stimulation in the cat. Acta Physiol Scand 1979;107:327-31
28. Ferrari MD, Odink J, Tapparelli C, Van KG, Penings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology 1989;39:1239-42
29. Anthony M, Lance JW. Plasma serotonin in patients with chronic tension headaches. J Neural Neurosurg Psychiatry 1989;52:182-4
30. Mezzano S, Kunick M, Olavarria F, Ardiles L, Aranda F., Mezzano D. Decreased platelet counts and decreased platelet serotonin in poststreptococcal nephritis. Nephron 1995;69:135-9
31. Singh KSP, Misra SS, Bhargava KP. 5-Hydroxytryptamine content of cerebrospinal fluid in leprosy. Nature 1965;206:206-7
32. Iacono RP, Kuniyoshi SM, Ahlman JR, Zimmerman GJ, Maeda G, Pearlstein RD. Concentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson's patients with severe postural instability and gait. J Neural Trans 1997;104:451-9
33. Brodner RA, Dohrmann GJ, Roth RK, Rubin RA. Correlation of cerebrospinal fluid serotonin and altered spinal cord blood flow in experimental trauma. Surg Neurol 1979;13:337-42
34. Lambert GA, Zagami AS, Bogduk N, Lance JW. Cervical spinal cord neurons receiving sensory input from the cranial vasculature. Cephalalgia 1991;11:75-85
35. Angus-Leppan H, Olausson B, Boers P, Lambert GA. Convergence of afferents from superior sagittal sinus and tooth pulp on cells in the upper cervical spinal cord of the cat. Neurosci Lett 1994;182:275-8
36. Angus-Leppan H, Lambert GA, Boers P, Lance JW, Zagami AS. Craniovascular nociceptive pathways relay in the upper cervical spinal cord in the cat. Neurosci Lett 1992;137:203-6
37. Angus-Leppan H, Lambert GA, Michalicek J. Convergence of occipital nerve and superior sagittal sinus input in the cervical spinal cord of the cat. Cephalalgia 1997;17:625-30
38. Anthony M, Hinterberger H, Lance JW. Studies of serotonin metabolism in migraine. Proc Aust Assoc Neural 1968;5:109-12
39. Vanhoutte PM. Cardiovascular effects of serotonin. J Cardiovasc Pharmacol 1987;10 Suppl 3:S8-11
40. Michalicek J, Lambert CA, Gordon V. Reactions of the middle meningeal artery of the cat to neural and humoral stimulation. Cephalalgia 1996;16:27-36
41. Ricciopo NF. The depolarising action of 5-HT on mammalian non-myelinated nerve fibres. Eur J Pharmacol 1978;49:351-6
42. O'Shaughnessy CT, Connor HE, Feniuk W. Extracellular recordings of membrane potential from guinea-pig isolated trigeminal ganglion: lack of effect of sumatriptan. Cephalalgia 1993;13:175-9
43. Elam R, Bergmann F, Feuerstein G Interaction of thyrotropinreleasing hormone (TRH) and serotonin in cardiovascular control. Eur J Pharmacol 1988;154:19-25
44. Erspamer V. Occurrence of indolealkylamines in nature. In: Handbuch der Experimentellen Pharmakologie. New York: Springer-Verlag, 1966:132-81
45. Lexchin JL, Cude-Simpson KD, Stanger HC. Brain and blood indole metabolites after peripheral administration of 14C-5HT in rat. Neurochem Res 1977;2:39-50
46. Bulat M, Supek Z. Passage of 5-hydroxtryptamine through the blood-brain barrier, its, metabolism in the brain and elimination of 5-hydroxyindoleacetic acid from the brain tissue. J Neurochem 1967;15:383-9
47. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1992;148:705-13
48. Portas CM, Thakkar M, Rainnie G, McCarley RW. Microdialysis perfusion of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in the dorsal raphe decreases serotonin release and increases rapid eye movement sleep in the freely moving cat. J Neurosci 1996;16:2820-8
49. Moskowitz MA, Liebmann JE, Reinhard JFJ, Schlosberg A. Raphe origin of serotonin-containing neurons within choroid plexus of the rat. Brain Res 1979;169:590-4
50. Verheyen A, Vlaminckx E, Lauwers F, Borgers M, Wouters L. Radioactive colloidal gold as a tool to quantify extravasation of macromolecules in the rat cremaster muscle. Int J Microcirc Clin Exp 1987;5:321-33
51. Boers P, Donaldson C, Zagami AS, Lambert GA. Alniditan modulates the trigeminovaseular system by an action at 5HT 1B/1D receptors. Cephalalgia 1998;18:400
52. Hoyer D, Clarke DE, Fozard JH, Hartig PB, Martin GR, Mylecharane EJ, et al. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203
53. Aimone LD, Jones SL, Gebhart GF. Stimulation-produced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal monoamines but not opioids. Pain 1987;31:123-36
54. Janss AJ, Gebhart GF. Spinal monoaminergic receptors mediate the antinociception produced by glutamate in the medullary lateral reticular nucleus. J Neurosci 1987;7: 2862-73
55. Carstens E, Fraunhoffer M, Zimmermann M. Serotonergic mediation of descending inhibition from midbrain periaqueductal gray but not reticular formation on spinal nociceptive transmission in the cat. Pain 1981;10:149-67